Scott R. Sammons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Scott R. Sammons has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Derek Kyle O'Flaherty
University of Guelph
6 shared publications - Jagandeep S. Saraya
Department of Chemistry, University of Guelph, 50 Stone Rd E, Guelph, Canada, N1G 2W1
3 shared publications - James D. Robinson
University of Guelph
2 shared publications - Constantin Giurgiu
Harvard University
1 shared publication - Jack W. Szostak
Department of Chemistry, The University of Chicago
1 shared publication - Nicholas G. Horton
University of Guelph
1 shared publication
Latest Publications
- Open Access
- 23 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
A Potentially Prebiotic Synthesis of a 3′-Amino-3′-deoxyribonucleoside
A central challenge in origins of life research is understanding how primitive genetic polymers could have replicated nonenzymatically prior to the evolution of macromolecular catalysts. Such a process would have required the formation of inter-nucleotide linkages, high fidelity in nucleobase pairing, and the ability to produce oligomers of sufficient length within short timescales. While modern ribozymes capable of catalyzing phosphodiester bond formation provide a model for RNA-based catalysis, they require a typical minimum length of ~50 nucleotides, a size unlikely to arise spontaneously without enzymatic intervention. Studies have demonstrated that the substitution of the canonical 3′-OH group with the much more nucleophilic 3′-NH2 group significantly enhances nonenzymatic template-directed oligomerization, and may have enabled early genetic polymers to bypass the need for enzymatic catalysis. Here, we report the synthesis of a 3′-amino-3′-deoxyribocytidine from prebiotic feedstocks. Our results support the hypothesis that 3′-amino-modified ribonucleotides could have served as substrates for the nonenzymatic synthesis of phosphoramidate nucleic acids on the early Earth prior to the emergence of RNA and ribozymes.
- 23 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA Potentially Prebiotic Synthesis of a 3′-Amino-3′-deoxyribonucleoside
A central challenge in origins of life research is understanding how primitive genetic polymers could have replicated nonenzymatically prior to the evolution of macromolecular catalysts. Such a process would have required the formation of inter-nucleotide linkages, high fidelity in nucleobase pairing, and the ability to produce oligomers of sufficient length within short timescales. While modern ribozymes capable of catalyzing phosphodiester bond formation provide a model for RNA-based catalysis, they require a typical minimum length of ~50 nucleotides, a size unlikely to arise spontaneously without enzymatic intervention. Studies have demonstrated that the substitution of the canonical 3′-OH group with the much more nucleophilic 3′-NH2 group significantly enhances nonenzymatic template-directed oligomerization, and may have enabled early genetic polymers to bypass the need for enzymatic catalysis. Here, we report the synthesis of a 3′-amino-3′-deoxyribocytidine from prebiotic feedstocks. Our results support the hypothesis that 3′-amino-modified ribonucleotides could have served as substrates for the nonenzymatic synthesis of phosphoramidate nucleic acids on the early Earth prior to the emergence of RNA and ribozymes.
- Open Access
- 17 April 2025
- Published by Wiley in Chemistry – A European Journal
- Vol. 31 (26) , e202500448
A Robust Strategy for Introducing Amino‐Modifiers in Nucleic Acids: Enabling Novel Amino Tandem Oligonucleotide Synthesis in DNA and RNA
Amino‐modifiers are pivotal chemical modifications in nucleic acid scaffolds, serving applications ranging from (bio)conjugation to probing the origins of life. We report a simple, efficient, and cost‐effective methodology for the introduction of amino‐modifiers into DNA and RNA. This approach leverages a commercially available sulfonyl‐containing solid support, which is first converted into a mixed N ‐hydroxysuccinimide carbonate, enabling robust conjugation with primary and secondary amines whether nucleosidic or non‐nucleosidic. Oligonucleotides are synthesized via solid‐phase synthesis and purified using standard methods, with little to no modification. Building on this framework, we introduce a novel amino‐containing tandem oligonucleotide synthesis (aTOS) methodology, which facilitates the introduction of multiple terminal amino (or monophosphate) groups across two oligonucleotide strands. This innovative method broadens the toolkit for the introduction of amino modifications in nucleic acids, for applications in nucleic acid (bio)chemistry and biotechnology.
- 17 April 2025
- Published by Wiley in Chemistry – A European Journal
- Vol. 31 (26) , e202500448
Open AccessA Robust Strategy for Introducing Amino‐Modifiers in Nucleic Acids: Enabling Novel Amino Tandem Oligonucleotide Synthesis in DNA and RNA
Amino‐modifiers are pivotal chemical modifications in nucleic acid scaffolds, serving applications ranging from (bio)conjugation to probing the origins of life. We report a simple, efficient, and cost‐effective methodology for the introduction of amino‐modifiers into DNA and RNA. This approach leverages a commercially available sulfonyl‐containing solid support, which is first converted into a mixed N ‐hydroxysuccinimide carbonate, enabling robust conjugation with primary and secondary amines whether nucleosidic or non‐nucleosidic. Oligonucleotides are synthesized via solid‐phase synthesis and purified using standard methods, with little to no modification. Building on this framework, we introduce a novel amino‐containing tandem oligonucleotide synthesis (aTOS) methodology, which facilitates the introduction of multiple terminal amino (or monophosphate) groups across two oligonucleotide strands. This innovative method broadens the toolkit for the introduction of amino modifications in nucleic acids, for applications in nucleic acid (bio)chemistry and biotechnology.
- 2 January 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (1)
Cover Feature: Aqueous Compatible Post‐Synthetic On‐Column Conjugation of Nucleic Acids Using Amino‐Modifiers (ChemBioChem 1/2025)
- 2 January 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (1)
Cover Feature: Aqueous Compatible Post‐Synthetic On‐Column Conjugation of Nucleic Acids Using Amino‐Modifiers (ChemBioChem 1/2025)
- Open Access
- 13 November 2024
- Published by Wiley in ChemBioChem
- Vol. 26 (1) , e202400643
Aqueous Compatible Post‐Synthetic On‐Column Conjugation of Nucleic Acids Using Amino‐Modifiers
Nucleic acid conjugation methodologies involve linking the nucleic acid sequence to other (bio)molecules covalently. This typically allows for nucleic acid property enhancement whether it be for therapeutic purposes, biosensing, etc. Here, we report a streamlined, aqueous compatible, on‐column conjugation methodology using nucleic acids containing a site‐specific amino‐modifier. Both monophosphates and carboxylates were amenable to the conjugation strategy, allowing for the introduction of a variety of useful handles including azide, aryl, and hydrophobic groups in DNA. We find that an on‐column approach is superior to post‐synthetic template‐directed synthesis, mainly with respect to product purification and recovery.
- 13 November 2024
- Published by Wiley in ChemBioChem
- Vol. 26 (1) , e202400643
Open AccessAqueous Compatible Post‐Synthetic On‐Column Conjugation of Nucleic Acids Using Amino‐Modifiers
Nucleic acid conjugation methodologies involve linking the nucleic acid sequence to other (bio)molecules covalently. This typically allows for nucleic acid property enhancement whether it be for therapeutic purposes, biosensing, etc. Here, we report a streamlined, aqueous compatible, on‐column conjugation methodology using nucleic acids containing a site‐specific amino‐modifier. Both monophosphates and carboxylates were amenable to the conjugation strategy, allowing for the introduction of a variety of useful handles including azide, aryl, and hydrophobic groups in DNA. We find that an on‐column approach is superior to post‐synthetic template‐directed synthesis, mainly with respect to product purification and recovery.
- 1 November 2024
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 102 (11) , 706-713
Efficient synthesis of the 2-aminoimidazolium-bridged diguanosyl intermediate for nonenzymatic primer extension
Nonenzymatic genome replication has yet to be demonstrated experimentally. Recently, studies on the nonenzymatic primer extension mechanism mediated by nucleoside 5′-monophosphates (NMPs) activated with 2-aminoimidazole (2AI) have revealed that imidazolium-bridged dinucleotide intermediates (N*N) are responsible for the bulk of the chemical copying process. As a result, an efficacious synthetic pathway for producing these substrates is desirable. Standard dehydrative redox reaction between NMPs and 2AI can produce N*N in high yields for all homodimers, apart from riboguanosine 5′-monophosphate. Here, we report a vastly improved methodology for the preparation of G*G, by the introduction of a simple reverse-phase cation exchange step to increase the solubility of the mononucleotide. Our approach is more efficient, cost-effective, less time-consuming, and has better atom economy than the currently established methodology for this important molecule in primer extension studies.
- 1 November 2024
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 102 (11) , 706-713
Efficient synthesis of the 2-aminoimidazolium-bridged diguanosyl intermediate for nonenzymatic primer extension
Nonenzymatic genome replication has yet to be demonstrated experimentally. Recently, studies on the nonenzymatic primer extension mechanism mediated by nucleoside 5′-monophosphates (NMPs) activated with 2-aminoimidazole (2AI) have revealed that imidazolium-bridged dinucleotide intermediates (N*N) are responsible for the bulk of the chemical copying process. As a result, an efficacious synthetic pathway for producing these substrates is desirable. Standard dehydrative redox reaction between NMPs and 2AI can produce N*N in high yields for all homodimers, apart from riboguanosine 5′-monophosphate. Here, we report a vastly improved methodology for the preparation of G*G, by the introduction of a simple reverse-phase cation exchange step to increase the solubility of the mononucleotide. Our approach is more efficient, cost-effective, less time-consuming, and has better atom economy than the currently established methodology for this important molecule in primer extension studies.
- Open Access
- 26 August 2024
- Published by Wiley in Current Protocols
- Vol. 4 (8) , e1119
Preparation of 2‐Aminoimidazole‐Activated Substrates for the Study of Nonenzymatic Genome Replication
Nonenzymatic genome replication is thought to be an important process for primitive lifeforms, but this has yet to be demonstrated experimentally. Recent studies on the nonenzymatic primer extension mechanism mediated by nucleoside 5′‐monophosphates (NMPs) activated with 2‐aminoimidazole have revealed that imidazolium‐bridged dinucleotide intermediates (N*N) account for the majority of the chemical copying process. As a result, an efficacious synthetic pathway for producing substrates activated with an imidazoyl moiety is desirable. This article provides a detailed protocol for the standard dehydrative redox reaction between NMPs and 2‐aminoimidazole to produce nucleotide phosphoroimidazolides. In addition, we describe a similar synthetic pathway to produce N*N in high yields for homodimers. Finally, a simple reversed‐phase cation exchange step is described to increase NMP solubility, which significantly increases yields for certain substrates. This approach allows for an efficient and cost‐effective methodology to prepare high‐quality substrates utilized in origins‐of‐life studies. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1 : Synthesis of 2‐aminoimidazolephosphoroimidazolide‐activated cytidine Basic Protocol 2 : Synthesis of 2‐aminoimidazolium‐bridged dicytidyl intermediate Basic Protocol 3 : Cation exchange of guanosine 5′‐monophosphate disodium salt Alternate Protocol : Synthesis of cytidine 5′‐phosphoroimidazolide or 2‐aminoimidazolium‐bridged dicytidyl from cytidine 5′‐monophosphate disodium salt
- 26 August 2024
- Published by Wiley in Current Protocols
- Vol. 4 (8) , e1119
Open AccessPreparation of 2‐Aminoimidazole‐Activated Substrates for the Study of Nonenzymatic Genome Replication
Nonenzymatic genome replication is thought to be an important process for primitive lifeforms, but this has yet to be demonstrated experimentally. Recent studies on the nonenzymatic primer extension mechanism mediated by nucleoside 5′‐monophosphates (NMPs) activated with 2‐aminoimidazole have revealed that imidazolium‐bridged dinucleotide intermediates (N*N) account for the majority of the chemical copying process. As a result, an efficacious synthetic pathway for producing substrates activated with an imidazoyl moiety is desirable. This article provides a detailed protocol for the standard dehydrative redox reaction between NMPs and 2‐aminoimidazole to produce nucleotide phosphoroimidazolides. In addition, we describe a similar synthetic pathway to produce N*N in high yields for homodimers. Finally, a simple reversed‐phase cation exchange step is described to increase NMP solubility, which significantly increases yields for certain substrates. This approach allows for an efficient and cost‐effective methodology to prepare high‐quality substrates utilized in origins‐of‐life studies. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1 : Synthesis of 2‐aminoimidazolephosphoroimidazolide‐activated cytidine Basic Protocol 2 : Synthesis of 2‐aminoimidazolium‐bridged dicytidyl intermediate Basic Protocol 3 : Cation exchange of guanosine 5′‐monophosphate disodium salt Alternate Protocol : Synthesis of cytidine 5′‐phosphoroimidazolide or 2‐aminoimidazolium‐bridged dicytidyl from cytidine 5′‐monophosphate disodium salt